Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Breast Cancer Research and Treatment|May 4, 2024
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohortRodrigo Sánchez-Bayona, Alfonso Lopez de Sa, Yolanda Jerez Gilarranz, et al.
Cancer Research|July 29, 2021
Long Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular CarcinomaJuan P Unfried, Mikel Marín-Baquero, Ángel Rivera-Calzada, et al.
JACC. Clinical Electrophysiology|January 23, 2025
Intrapericardial Corticosteroids and Colchicine Prevent Pericarditis and Atrial Fibrillation After Epicardial Ablation of Ventricular ArrhythmiasJorge E Romero, Carlos D Matos, Fermin Garcia, et al.
Iscience|November 18, 2024
Erratum: Interlaboratory study on Sb<sub>2</sub>S<sub>3</sub> interplay between structure, dielectric function, and amorphous-to-crystalline phase change for photonicsYael Gutiérrez, Anna P Ovvyan, Gonzalo Santos, et al.
Iscience|May 27, 2022
Interlaboratory study on Sb<sub>2</sub>S<sub>3</sub> interplay between structure, dielectric function, and amorphous-to-crystalline phase change for photonicsYael Gutiérrez, Anna P Ovvyan, Gonzalo Santos, et al.
Therapeutic Advances in Medical Oncology|February 6, 2023
Quality of life with palbociclib plus fulvestrant <i>versus</i> placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trialAriadna Tibau, M Teresa Martínez, Manuel Ramos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2018
Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined ClassificationIsabel Echavarria, Sara López-Tarruella, Antoni Picornell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast CancerMiguel Quintela-Fandino, Begoña Bermejo, Esther Zamora, et al.
Cancers|November 13, 2021
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) StudyLuis de la Cruz-Merino, María Gion, Josefina Cruz-Jurado, et al.
Scientific Reports|March 30, 2021
Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenograftsMiguel Martin, Rocio Ramos-Medina, Rebeca Bernat, et al.
Pageof 26